Pacira BioSciences, Inc. — Director's Dealing 2015

Mar 19, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2015-03-17

Reporting Person: Markvicka Taunia (SVP, Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-17	Common Stock	M	8349	$5.49	Acquired	8579	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-17	Employee Stock Option (Right to Buy)	$5.49	M	8349	Disposed	2020-12-28	Common Stock (8349)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	230	Indirect

Footnotes

F1: Includes 230 shares of common stock acquired under the issuer's employee stock purchase plan in December 2014.

F2: The stock option vests as follows: 25% of the options vested on December 29, 2011, and the remaining options vested in successive equal monthly installments over the subsequent 36 months.